Spectral AI (NasdaqCM:MDAI) Q4 2025 Earnings call March 24, 2026 05:00 PM ET Company ParticipantsDevin Sullivan - Managing DirectorThomas Spieth - Corporate ControllerVincent Capone - CEOConference Call ParticipantsCarl Byrnes - Managing Director and Senior Research AnalystJohn Vandermosten - Senior AnalystRaghuram Selvaraju - Managing Director and Senior Healthcare AnalystRyan Zimmerman - Managing Director and Medical Technology AnalystOperatorI would now like to turn the conference over to Devin Sullivan, ...

Spectral AI (NasdaqCM:MDAI) Q4 2025 Earnings call March 24, 2026 05:00 PM ET Company ParticipantsDevin Sullivan - Managing DirectorThomas Spieth - Corporate ControllerVincent Capone - CEOConference Call ParticipantsCarl Byrnes - Managing Director and Senior Research AnalystJohn Vandermosten - Senior AnalystRaghuram Selvaraju - Managing Director and Senior Healthcare AnalystRyan Zimmerman - Managing Director and Medical Technology AnalystOperatorI would now like to turn the conference over to Devin Sullivan, ...

Spectral AI (NasdaqCM:MDAI) Q4 2025 Earnings call March 24, 2026 05:00 PM ET Speaker3I would now like to turn the conference over to Devin Sullivan, Managing Director of The Equity Group. Please go ahead.Speaker1Thank you, Gary. Good afternoon, everyone, and thank you for joining us today for Spectral AI's 2025 fourth quarter and full year financial results conference call. Our speakers for today will be Vincent Capone, the company's Chief Executive Officer, and Thomas Spieth, our Corporate Controller. Befo ...

Overview Full Year Research & Development Revenue of $19.7 Million; Q4 2025 Revenue of $3.8 MillionCash Rose to $15.4 Million at December 31, 2025 DALLAS, March 24, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (“AI”) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the fourth quarter (“Q4 2025”) and full year (“FY 2025”) ended December 31, 2025 ...

Group 1 - Spectral AI stock has seen significant gains, attributed to recent funding developments and positive investor sentiment [1][3] - The company received immediate, non-dilutive funding from BARDA, adding to the previously committed $54.9 million under an existing contract, which has a total potential value of up to $150 million [2] - Spectral AI will contribute an additional $9.7 million towards the development costs associated with advancements in their technology [2] Group 2 - The funding will support the development of the DeepView System, which is aimed at enhancing FDA clearance efforts and expediting Phase II initiatives, including total body surface area mapping [4] - DeepView is designed for use in emergency departments, trauma centers, and burn centers, facilitating faster, data-driven clinical treatment decisions in wound care [5] - As of Thursday morning, Spectral AI shares increased by 8.33%, reaching a price of $1.30 [7]

DALLAS, March 18, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has received $31.7 million in funding from the Biomedical Advanced Research and Development Authority (“BARDA”) to accelerate and support additional feature aspects for the Company’s DeepView® System, its AI-driven burn wound imaging technolog ...

DALLAS, March 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2025 on Tuesday, March 24, 2026 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day t ...

Core Viewpoint - Spectral AI, Inc. has appointed Vincent S. Capone as Chief Executive Officer, effective February 9, 2026, as the company moves towards the commercialization of its AI-driven burn wound assessment device, the DeepView System [1][2]. Company Leadership - Vincent S. Capone, previously the Chief Financial Officer and General Counsel, is recognized for his leadership skills and vision for the company's future, having played a crucial role in its development [3]. - Dr. J. Michael DiMaio, Chairman of the Board, expressed confidence in Capone's ability to guide the company strategically as it evolves [3]. Product Development - The DeepView System is a proprietary, non-invasive device aimed at providing clinicians with an objective assessment of burn wounds, marking a significant advancement in wound care [2][5]. - The FDA submission for the DeepView System occurred in June 2025, representing a major milestone for the company [4]. Company Mission - Spectral AI aims to revolutionize wound care management by offering fast and accurate treatment insights, ultimately improving patient outcomes and reducing healthcare costs [5]. - The company has been recognized in TIME's list of World’s Top HealthTech companies for 2025, highlighting its innovative approach in the healthcare sector [5].

Core Insights - Spectral AI, Inc. is collaborating with the American Burn Association (ABA) to promote burn prevention strategies during National Burn Awareness Week [1][2][3] - The company is focused on enhancing medical diagnostics for wound care through its DeepView® System, which provides predictive assessments for burn wounds [4][9] Company Initiatives - Spectral AI will engage employees with activities that include leadership messages and personal stories from biomedical engineers to emphasize innovation in burn care [2] - The company aims to raise awareness about burn prevention and educate workplaces on proactive safety measures [3][5] Product Development - The DeepView® System, submitted for FDA approval, combines multispectral imaging and AI to predict the healing potential of burn wounds, allowing for timely treatment decisions [4][9] - This system is designed to provide non-healing predictions on the same day of injury and up to seven days post-injury, potentially improving patient outcomes [4] Industry Context - Burn injuries are a significant public health issue in the U.S., with approximately 600,000 individuals requiring emergent care annually due to burn injuries [5] - The ABA's theme for this year emphasizes the importance of preventing burns in various environments, including workplaces [2][6] Safety Recommendations - The ABA has outlined five key burn prevention tips, including wearing protective gear, handling heat safely, inspecting equipment, controlling flammables, and knowing emergency procedures [7]

Core Insights - Spectral AI, Inc. is actively participating in regional burn conferences to showcase its innovative DeepView System, aimed at improving burn care through AI-driven diagnostics [1][2][3] Company Overview - Spectral AI is a Dallas-based predictive AI company focused on medical diagnostics, particularly in wound care, with initial applications for burn patients [3] - The DeepView System is designed to provide objective assessments of burn wounds, enhancing treatment decisions and potentially reducing healthcare costs [3] Conference Participation - The company was featured prominently at the Southern Region Burn Conference from October 30th to November 2nd, 2025, in Charleston, South Carolina, highlighting its contributions to burn care [1][2] - The upcoming Northeast Region Burn Conference will take place from November 21st to 22nd, 2025, in Washington, DC, further emphasizing the company's commitment to advancing burn care through education and collaboration [2] Expert Endorsements - Dr. James Hwang from UAB Burn Center emphasized the importance of the DeepView System in promoting evidence-based decisions in burn assessment, which can lead to improved patient outcomes [2] - Dr. J. Michael DiMaio, Chairman of the Board, expressed pride in the company's role at the conferences, underscoring the value of physician collaboration in introducing innovative technologies [3] Industry Recognition - Spectral AI has been recognized on TIME's list of World's Top HealthTech companies for 2025, indicating its growing influence and reputation in the healthcare technology sector [3]